CDS’ eClinical platform, TrialKit, now offers sponsors and CROs the ability to create global registries in which the public can…
In this guest post from TruLab, Inc., Lindsey Lanier walks us through the problems with the current approach to bio sample management and how we can increase efficiencies and achieve better outcomes by leveraging the latest in technology – including blockchain.
Together, CDS and SAT are leveraging the latest mobile and wearable technologies to achieve remote, longitudinal tracking of biomarkers in…
CDS has many innovative updates in store for TrialKit in 2021. Check out this blog post for a quick glance at what’s to come to the platform in the upcoming year.
The trends infiltrating the clinical research industry – wearable integrations, mobile apps, machine learning, and more – aren’t just exciting concepts. They’re made possible and are now being used in studies with today’s technology.
Increased demand for eClinical technology to support growing demand for remote studies contributes to CDS’ YoY growth and expanded customer…
What are the current challenges in the clinical industry today, and what steps can we take to overcome them? This blog post recounts the discussion our panel of experts had on this very topic in our recent webinar, Bridging the Gap to the New Clinical Trial Landscape.
The TrialKit platform received updates to its eConsent and ePRO modules to advance remote data collection and management
In forming an academic partnership, Durham Tech’s clinical trials program is utilizing TrialKit, CDS’ data collection and study management platform.
A new wave of interest in virtual trials has been generated by the coronavirus pandemic. But will the enthusiasm remain after the conclusion of the pandemic? In this post, we provide our perspective on why the virtual trial may be here to stay.